| scholarly article | Q13442814 |
| P2093 | author name string | Richard P Phipps | |
| Ajay E Kuriyan | |||
| Steven E Feldon | |||
| Charles W O'Loughlin | |||
| Collynn F Woeller | |||
| P2860 | cites work | Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy | Q79231560 |
| Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link | Q79259989 | ||
| Thyroid eye disease | Q83446693 | ||
| Graves' ophthalmopathy | Q28274196 | ||
| A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation | Q29619212 | ||
| Increased generation of fibrocytes in thyroid-associated ophthalmopathy | Q33586738 | ||
| Graves' ophthalmopathy: II. Correlation of clinical signs with measures derived from computed tomography | Q33646613 | ||
| The eye and thyroid disease | Q34014090 | ||
| Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy | Q34062319 | ||
| Novel anti-adipogenic activity produced by human fibroblasts. | Q34149741 | ||
| Imaging in thyroid-associated orbitopathy | Q34309119 | ||
| Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer | Q34331195 | ||
| The pathophysiology of thyroid-associated ophthalmopathy | Q34684417 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts | Q34998187 | ||
| Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes | Q35222158 | ||
| Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management | Q35866148 | ||
| Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment | Q36525240 | ||
| Immune mechanisms in thyroid eye disease. | Q37254482 | ||
| Graves' ophthalmopathy: current concepts regarding pathogenesis and management | Q39489563 | ||
| Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring | Q40430999 | ||
| Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease | Q40601963 | ||
| Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis | Q40625104 | ||
| Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib | Q42566773 | ||
| Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts | Q43845891 | ||
| Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy | Q43853007 | ||
| Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes | Q43867818 | ||
| Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy | Q43958341 | ||
| Association of thy-1 cell surface differentiation antigen with certain connective tissues in vivo | Q44421119 | ||
| Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy | Q46113795 | ||
| Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience | Q47945181 | ||
| Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. | Q53611171 | ||
| Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues of Graves' ophthalmopathy patients. | Q54574733 | ||
| Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle | Q70297118 | ||
| Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts | Q72055491 | ||
| Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists | Q72754868 | ||
| Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy | Q73194238 | ||
| CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts | Q73326047 | ||
| Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy | Q73555606 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 7370-7377 | |
| P577 | publication date | 2013-11-08 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype | |
| P478 | volume | 54 |
| Q47814599 | Complications and outcomes of grafting of posterior orbital fat into the lower lid-cheek junction during orbital decompression |
| Q27691806 | Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. |
| Q51125236 | Cytokine profiles in clinical subtypes of ophthalmic Graves' disease. |
| Q40095263 | Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management |
| Q90894014 | Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy |
| Q38293593 | Management of strabismus in thyroid eye disease |
| Q35738996 | Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2 |
| Q38633022 | Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. |
| Q47114849 | Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity |
| Q47121440 | RNA-Sequencing Gene Expression Profiling of Orbital Adipose-Derived Stem Cell Population Implicate HOX Genes and WNT Signaling Dysregulation in the Pathogenesis of Thyroid-Associated Orbitopathy |
| Q36833918 | Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy |
| Q35055573 | Salinomycin and other polyether ionophores are a new class of antiscarring agent |
| Q36738202 | Severe Ophthalmological Complications of Thyroid Disease are Rare in Ibadan, Southwestern Nigeria: Results of a Pilot Study |
| Q35900410 | Surgical Responses of Medial Rectus Muscle Recession in Thyroid Eye Disease-Related Esotropia |
| Q38795531 | The Aryl Hydrocarbon Receptor and Its Ligands Inhibit Myofibroblast Formation and Activation: Implications for Thyroid Eye Disease |
| Q95322318 | The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts |
Search more.